LDE225 + Everolimus in Advanced Gastroesophageal Adenocarcinoma
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT02138929 |
|
Recruitment Status :
Completed
First Posted : May 15, 2014
Last Update Posted : June 11, 2020
|
Sponsor:
M.D. Anderson Cancer Center
Collaborators:
Novartis
National Cancer Institute (NCI)
Information provided by (Responsible Party):
M.D. Anderson Cancer Center
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Completed |
|---|---|
| Actual Primary Completion Date : | June 8, 2020 |
| Actual Study Completion Date : | June 8, 2020 |